The treatment of Alzheimer's disease - Wikidata - wikimedia - TriplyDB

The treatment of Alzheimer's disease

The treatment of Alzheimer's disease

http://www.wikidata.org/entity/Q57526641

about

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.Cultures of cells from fetal rat brain: methods to control composition, morphology, and biochemical activity.

P2860

Q37369200-52505D6B-C7F1-4E21-8752-C899A129B6F6 Q48297912-A777B6C4-9AA4-4712-B64E-439930677FC6

P2860

The treatment of Alzheimer's disease

http://www.wikidata.org/entity/Q57526641

description

im Januar 1995 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 January 1995

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 1995

@uk

name

The treatment of Alzheimer's disease

@en

The treatment of Alzheimer's disease

@nl

type

label

The treatment of Alzheimer's disease

@en

The treatment of Alzheimer's disease

@nl

prefLabel

The treatment of Alzheimer's disease

@en

The treatment of Alzheimer's disease

@nl

P1433

Q57526641-FFFCF253-7ABF-4060-B837-CD222CC05855

P1476

Q57526641-275BB453-D074-45C6-BE50-ABCBB98E6E18

P2093

Q57526641-66E93081-2158-4C1A-9178-F55EAE8E9492

P2860

Q57526641-03946D99-494A-4ED5-81A8-AEE53088CA69

Q57526641-0470804C-7A50-4345-8A4C-9F6028D88A14

Q57526641-053C1766-E260-4EA0-9746-520D61E498B5

Q57526641-062F80AE-D502-4C31-AFAE-A73BCF1B8762

Q57526641-07F6AC93-4787-4566-97E6-897AAEFEA96F

Q57526641-09CEB314-B6A1-4CCD-8DE2-8E1A300CB830

Q57526641-0A1C7799-5127-411F-8230-D85847E47F2C

Q57526641-0CB4360C-FAF2-4D3A-8972-42E0DA587A08

Q57526641-0D00901C-F539-401E-B84A-08542157CC17

Q57526641-0F195C66-0DA3-48D6-95BC-5A737206EDB6

P304

Q57526641-EC041194-41BE-461C-93E0-69D36791A392

P31

Q57526641-6B7468EF-D58A-460C-9F9D-D7A5DC740A90

P356

Q57526641-08526A55-127E-487E-8099-C219CC6CDBF5

P407

Q57526641-F22F77AD-69E1-4FDB-8105-A11F05DFE130

P433

Q57526641-609658A4-D29D-4238-BFA4-76D7F0963E59

P478

Q57526641-25AF8EBE-D844-476B-9F28-294EDDCA241F

P50

Q57526641-55A0A4C0-C29B-46CF-9249-00E53ED8B25A

P577

Q57526641-3FB55DF9-2845-4358-9B0C-1F173415C989

P698

Q57526641-303E6970-B228-4D6C-9F57-A10303DF8321

P356

026988119500900108

P1433

Journal of Psychopharmacology

P1476

The treatment of Alzheimer's disease

@en

P2093

N H Allen

http://www.w3.org/2001/XMLSchema#string

P2860

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease

Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Identification of a family of muscarinic acetylcholine receptor genes

Neurotrophin-3: a neurotrophic factor related to NGF and BDNF

A pilot placebo-controlled study of chronic m-CPP administration in Alzheimer's disease

Long-term acetyl-L-carnitine treatment in Alzheimer's disease

Alzheimer's disease: the amyloid cascade hypothesis

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

P304

43-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/026988119500900108

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

1995-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22298693

http://www.w3.org/2001/XMLSchema#string